Dr. Lal Pathlabs
Ticker >

Dr. Lal Pathlabs share price

Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB BSE: 539524 SECTOR: Hospital & Healthcare Services  204k   1k   306

2779.90
+0.85 (0.03%)
BSE: Today, 09:06 AM

Price Summary

Today's High

₹ 0

Today's Low

₹ 0

52 Week High

₹ 2889.45

52 Week Low

₹ 1943.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 23206.7 Cr.

Enterprise Value

₹ 22606.92 Cr.

No. of Shares

8.35 Cr.

P/E

60.38

P/B

12.55

Face Value

₹ 10

Div. Yield

0.86 %

Book Value (TTM)

₹  221.45

CASH

₹ 683.12 Cr.

DEBT

₹ 83.33 Cr.

Promoter Holding

54.6 %

EPS (TTM)

₹  46.04

Sales Growth

11.18%

ROE

22.09 %

ROCE

27.77%

Profit Growth

31.47 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 19 Indices.

NIFTY200

Nifty 200
13635.3
  -33.4000000000015 (-0.244353888811677%)

NIFTY500

Nifty 500
22677.8
  -49.7999999999993 (-0.219116844717437%)

NIFTYHEALTH

Nifty Healthcare Index
12555.3
  -40.1500000000015 (-0.318765903560425%)

NIFTYLGEMID250

NIFTY LargeMidcap 250
15821.5
  -56.5 (-0.355838266784225%)

NIFTYMIDCAP

NIFTY Midcap 100
55854.7
  -437.800000000003 (-0.777723497801663%)

NIFTYMIDCAP150

Nifty Midcap 150
20909.9
  -120 (-0.570616122758549%)

NIFTYMIDSMALL400

Nifty MidSmallcap 400
19669.3
  -84.0499999999993 (-0.42549744726843%)

NIFTYTOTALMCAP

Nifty Total Market index
12769.65
  -26.2000000000007 (-0.20475388504867%)

NMID150Q50

NIFTY Midcap150 Quality 50
24708.45
  0.700000000000728 (0.00283311916302598%)

NY500MUL50:25:25

Nifty500 Multicap 50:25:25
15850.9
  -40.3500000000004 (-0.253913317077015%)

NIFTYFULLMIDCAP100

NIFTY FULL MIDCAP 100
5987.56
  -42.7999999999993 (-0.709742038617911%)

BSE500

S&P Bse 500
35821.13
  -73.2700000000041 (-0.204126548988159%)

BSE HC

S&P Bse Healthcare
37159.26
  -91.9599999999991 (-0.246864397998237%)

SMLCAP

S&P Bse Small Cap
52988.28
  36.5499999999956 (0.0690251291128652%)

S&P MIDSMLCAP

S&P Bse MidSmallCap
13271.46
  -31.1500000000015 (-0.234164573718998%)

ALLCAP

S&P Bse Allcap
10468.27
  -17.1299999999992 (-0.163370019264875%)

SMLSEL

S&P Bse SmallCap Select Index
7835.39
  -39.2699999999995 (-0.498688197331687%)

SML250

S&P Bse 250 SmallCap
6999.81
  -12.3499999999995 (-0.176122621275032%)

MSL400

S&P Bse 400 MidSmallCap
12072.65
  -51.5200000000004 (-0.4249363049182%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year11.18%
3 Year9.68%
5 Year11.04%

Profit Growth

1 Year31.47%
3 Year11.12%
5 Year14.48%

ROE%

1 Year22.09%
3 Year22.64%
5 Year23.5%

ROCE %

1 Year27.77%
3 Year27.58%
5 Year30.04%

Debt/Equity

0.0451

Price to Cash Flow

48.59

Interest Cover Ratio

20.2268

CFO/PAT (5 Yr. Avg.)

1.29564266453021

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 54.6 0
Dec 2023 54.6 0
Sep 2023 54.61 0
Jun 2023 55.01 0
Mar 2023 55.03 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 153.337 Cr.
  • Company has been maintaining healthy ROE of 22.6400976043492% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.5837463106687% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 20.2268.
  • The Company has been maintaining an effective average operating margins of 26.9646599702361% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -125.7881 days.
  • Company has a healthy liquidity position with current ratio of 2.1688.
  • The company has a good cash flow management; CFO/PAT stands at 1.29564266453021.
  • The company has a high promoter holding of 54.6%.

 Limitations

  • The company has shown a poor revenue growth of 9.68163233722905% for the Past 3 years.
  • The company is trading at a high PE of 60.38.
  • The company is trading at a high EV/EBITDA of 36.4784.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 431 480.1 531.7 476 479
Total Expenditure 315.3 344.3 368.7 345.9 348.7
Operating Profit 115.7 135.8 163 130.1 130.3
Other Income 11.6 15 14.1 15.1 15.9
Interest 8.4 7.3 7.1 6.5 5.9
Depreciation 20.8 18.4 19.1 19.2 19.8
Exceptional Items 0 0 0 0 0
Profit Before Tax 98.1 125.1 150.9 119.5 120.5
Tax 26.7 31.5 37.9 31.2 31
Profit After Tax 71.4 93.6 113 88.3 89.5
Adjusted EPS (Rs) 8.56 11.22 13.53 10.57 10.72

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1273.6 1490.56 1878.79 1769.03 1966.76
Total Expenditure 945.79 1083.18 1366.32 1308.33 1407.52
Operating Profit 327.81 407.38 512.47 460.7 559.24
Other Income 57.61 51.27 53.1 46.6 60.11
Interest 14.66 14.83 28.63 34.38 26.84
Depreciation 68.01 69.78 75.94 82.09 76.54
Exceptional Items 0 0 0 0 0
Profit Before Tax 302.75 374.04 460.99 390.83 515.97
Tax 79.57 93.94 115.74 98.47 131.6
Net Profit 223.18 280.11 345.25 292.36 384.37
Adjusted EPS (Rs.) 26.78 33.61 41.42 35.07 46.04

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 83.35 83.35 83.35 83.37 83.48
Total Reserves 932.94 1133.74 1388.77 1606.5 1816.18
Borrowings 0 0 166.67 83.33 0
Other N/C liabilities 68.18 76.83 90.73 82.26 52.71
Current liabilities 211.29 252.25 451.04 432.16 424.44
Total Liabilities 1295.75 1546.16 2180.55 2287.62 2376.81
Assets
Net Block 296.53 300.07 370.95 361.48 308.97
Capital WIP 10.3 5.51 14.45 2.97 3.95
Intangible WIP 0.99 3.48 0 1.97 1.7
Investments 93.88 120.4 1061.81 1072.03 1072.8
Loans & Advances 18.43 23.87 24.33 19.89 19.97
Other N/C Assets 13.21 3.53 9.71 19.11 48.88
Current Assets 862.41 1089.3 699.31 810.17 920.55
Total Assets 1295.75 1546.16 2180.55 2287.62 2376.81
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 302.75 374.04 460.99 390.83 515.97
Adjustment 45.84 59.1 87.81 96.31 64.29
Changes in Assets & Liabilities 12.57 37.33 -5.55 39.52 22.76
Tax Paid -89.17 -97.12 -117.53 -99.13 -125.42
Operating Cash Flow 271.99 373.36 425.73 427.53 477.6
Investing Cash Flow -19.47 -195.19 -448.53 -288.47 31.91
Financing Cash Flow -187.22 -135.74 141.24 -270.05 -404
Net Cash Flow 65.3 42.42 118.43 -130.99 105.51

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 55.03 55.01 54.61 54.60 54.60
anjaneya lal - - - - 2.02
archana lal erdmann 2.03 2.03 2.03 2.03 2.03
arvind lal - - - - 31.28
vandana lal - - - - 19.27
anjaneya lal 2.03 2.03 2.02 2.02 -
arvind lal 31.69 31.67 31.29 31.28 -
vandana lal 19.29 19.28 19.27 19.27 -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 44.97 44.99 45.39 45.40 45.40
al mehwar commercial inve... - - - - 1.06
first sentier investors i... 1.14 1.14 - - 1.14
invesco oppenheimer inter... 2.92 2.89 2.89 2.69 3.80
life insurance corporatio... 1.48 1.48 1.48 1.47 1.47
llp 0.07 0.06 0.05 0.04 0.03
om prakash manchanda 1.39 1.28 1.25 1.23 1.16
uti flexi cap fund 2.27 2.81 2.96 2.97 3.07
wasatch emerging india fu... - - - 1.02 1.02
al mehwar commercial inve... 1.06 1.06 - 1.06 -
first sentier investors i... - - - 1.14 -
al mehwar commercial inv... - - 1.06 - -
first sentier investors i... - - 1.14 - -
westbridge crossover fund... 1.83 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Dr. Lal PathLabs informs about newspaper advertisements6 Jun 2024, 3:48PM Dr. Lal Pathlabs - Quaterly Results10 May 2024, 1:40PM Dr. Lal Pathlabs - Quaterly Results10 May 2024, 1:40PM Dr. Lal Pathlabs - Quaterly Results10 May 2024, 1:40PM Dr. Lal PathLabs informs about board meeting 3 May 2024, 10:49AM Dr. Lal PathLabs informs about closure of trading window 26 Mar 2024, 2:59PM Dr. Lal PathLabs informs about outcome of committee meet18 Mar 2024, 8:16AM Dr. Lal PathLabs informs about earnings presentation1 Feb 2024, 3:46PM Dr. Lal Pathlabs - Quaterly Results1 Feb 2024, 1:30PM Dr. Lal Pathlabs - Quaterly Results1 Feb 2024, 1:30PM Dr. Lal Pathlabs - Quaterly Results1 Feb 2024, 1:30PM Dr. Lal PathLabs informs about conference call25 Jan 2024, 2:34PM Dr. Lal PathLabs informs about board meeting 25 Jan 2024, 2:22PM Dr. Lal PathLabs informs about closure of trading window25 Jan 2024, 12:34PM Dr. Lal PathLabs informs about allotment of equity shares under ESOP17 Nov 2023, 2:30PM Dr. Lal Pathlabs - Quaterly Results2 Nov 2023, 1:37PM Dr. Lal Pathlabs - Quaterly Results2 Nov 2023, 1:37PM Dr. Lal Pathlabs - Quaterly Results2 Nov 2023, 1:37PM Dr. Lal PathLabs informs about analyst meet 15 Sep 2023, 12:12PM Dr. Lal PathLabs informs about AGM 17 Aug 2023, 5:16PM Dr. Lal PathLabs informs about BRSR 17 Aug 2023, 5:10PM Dr. Lal PathLabs informs about transcript of conference call2 Aug 2023, 12:53PM Dr. Lal Pathlabs - Quaterly Results27 Jul 2023, 2:28PM Dr. Lal Pathlabs - Quaterly Results27 Jul 2023, 2:28PM Dr. Lal Pathlabs - Quaterly Results27 Jul 2023, 2:28PM Dr. Lal PathLabs submits board meeting intimation20 Jul 2023, 12:52PM Dr. Lal PathLabs informs about trading window closure30 Jun 2023, 10:39AM Dr. Lal PathLabs informs about analyst meet9 Jun 2023, 11:04AM Dr. Lal PathLabs informs about analyst meet5 Jun 2023, 5:10PM Dr. Lal PathLabs submits analyst meet intimation2 Jun 2023, 4:44PM Dr. Lal PathLabs informs about analyst meet 16 May 2023, 10:27AM Dr. Lal PathLabs submits analyst meet intimation15 May 2023, 5:03PM Dr. Lal Pathlabs reports 8% fall in Q4 consolidated net profit 11 May 2023, 4:51PM Dr. Lal Pathlabs - Quaterly Results11 May 2023, 2:04PM Dr. Lal Pathlabs - Quaterly Results11 May 2023, 2:04PM Dr. Lal Pathlabs - Quaterly Results11 May 2023, 2:04PM Dr. Lal PathLabs informs about conference call8 May 2023, 12:45PM Dr. Lal PathLabs submits analyst meet intimation30 Mar 2023, 3:43PM Dr. Lal PathLabs submits analyst meet intimation27 Mar 2023, 2:44PM Dr. Lal PathLabs informs about institutional investor meeting23 Mar 2023, 10:41AM Dr. Lal PathLabs informs about resignation of company secretary 21 Mar 2023, 1:14PM Dr. Lal PathLabs informs about analyst meet 17 Mar 2023, 10:45AM Dr. Lal PathLabs selects Kyndryl to manage IT infrastructure stack15 Mar 2023, 3:08PM Dr. Lal PathLabs informs about analyst meet 15 Mar 2023, 9:54AM Dr. Lal PathLabs informs about analyst meet 2 Mar 2023, 3:12PM Dr. Lal PathLabs informs about analyst meet 23 Feb 2023, 12:31PM Dr. Lal PathLabs informs about analyst meet 17 Feb 2023, 10:09AM Dr. Lal PathLabs informs about analyst meet7 Feb 2023, 3:17PM Dr. Lal PathLabs informs about institutional investor meeting6 Feb 2023, 4:58PM Dr. Lal Pathlabs - Quaterly Results2 Feb 2023, 2:16PM

Dr. Lal Pathlabs Stock Price Analysis and Quick Research Report. Is Dr. Lal Pathlabs an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Dr. Lal Pathlabs and its performance over the period of time. Dr. Lal Pathlabs stock price today is Rs 2780.5.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Dr. Lal Pathlabs cash from the operating activity was Rs 477.599 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Dr. Lal Pathlabs has a Debt to Equity ratio of 0.0451 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Dr. Lal Pathlabs , the EPS growth was 31.2991 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Dr. Lal Pathlabs has OPM of 28.4346116807457 % which is a good sign for profitability.
     
  • ROE: Dr. Lal Pathlabs have a healthy ROE of 22.0871 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Dr. Lal Pathlabs is Rs 2780.5. One can use valuation calculators of ticker to know if Dr. Lal Pathlabs share price is undervalued or overvalued.
Last Updated on:
Brief about Dr. Lal Pathlabs

Dr. Lal Pathlabs Ltd Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

 

Dr. Lal Pathlabs Ltd. is a leading provider of diagnostic healthcare services in India. Long-term investors interested in investing in healthcare companies need to conduct a comprehensive stock analysis of Dr. Lal Pathlabs Ltd. The analysis should include essential factors like balance sheet, annual report, dividend, quarterly results, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Dr. Lal Pathlabs Ltd. Share Price

The share price of Dr. Lal Pathlabs Ltd. is a crucial factor to consider when analyzing the company for long-term investment. The share price is influenced by various factors, including market trends, financial performance, and investor sentiment. Ticker pre-built screening tools provide real-time updates on the share price of Dr. Lal Pathlabs Ltd., helping investors stay informed about price fluctuations and market trends.

Dr. Lal Pathlabs Ltd. Balance Sheet

Analyzing the balance sheet of Dr. Lal Pathlabs Ltd. is essential to understand the financial stability and performance of the company. The balance sheet provides a snapshot of the company's assets, liabilities, and shareholders' equity. Dr. Lal Pathlabs Ltd.'s balance sheet is analyzed using tools like DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, allowing investors to calculate fair value based on the balance sheet.

Dr. Lal Pathlabs Ltd. Annual Report

Dr. Lal Pathlabs Ltd. annual report provides comprehensive details about the company's financial performance, strategic initiatives, and future prospects. Investors can access and download the annual report directly from Ticker to gain a deeper understanding of Dr. Lal Pathlabs Ltd.'s performance and make well-informed investment decisions.

Dr. Lal Pathlabs Ltd. Dividend

Dr. Lal Pathlabs Ltd. provides dividends as a way to share its profits with shareholders. Dividends are a crucial consideration for long-term investors, as they demonstrate the company's commitment to returning value to shareholders. By monitoring dividend payments through Ticker pre-built screening tools, investors can stay updated on the latest dividend announcements and assess the company's dividend history.

Dr. Lal Pathlabs Ltd. Quarterly Results

Analyzing the quarterly results of Dr. Lal Pathlabs Ltd. provides crucial information about the company's growth and profitability over specific periods. By monitoring revenue, expenses, and profits, investors can assess the company's performance and make informed investment decisions. Dr. Lal Pathlabs Ltd.'s financial information is analyzed using tools like Earnings multiple approaches and DuPont analysis, enabling long-term investors to make informed investment decisions.

Dr. Lal Pathlabs Ltd. Stock Price

The stock price of Dr. Lal Pathlabs Ltd. is influenced by various factors, including market trends, financial performance, and investor sentiment. Tracking the stock price helps investors gain insights into the market's reaction to the company's performance and news. Ticker pre-built screening tools provide real-time updates on the stock price of Dr. Lal Pathlabs Ltd., allowing investors to stay informed about price movements and make well-informed decisions.

Dr. Lal Pathlabs Ltd. Price Chart

The price chart of Dr. Lal Pathlabs Ltd. visually represents the historical trends of the stock price. By analyzing the chart, long-term investors can identify patterns and trends that may impact future stock performance. The price chart is a valuable tool for assessing the potential investment value of Dr. Lal Pathlabs Ltd. and making informed decisions.

Dr. Lal Pathlabs Ltd. News

Staying updated with the latest news about Dr. Lal Pathlabs Ltd. is crucial for long-term investors conducting a stock analysis. Ticker provides access to the company's news, including press releases, analyst reports, and market updates. This ensures investors can keep track of changes and developments in the company and make informed investment decisions.

Dr. Lal Pathlabs Ltd. Concall

Participating in Dr. Lal Pathlabs Ltd.'s concall allows investors to hear directly from the management team. The concall offers valuable insights into the company's financial performance, strategic initiatives, and future plans. Investors can access the transcripts of the concall on Ticker, enabling them to review and refer to the discussions.

Dr. Lal Pathlabs Ltd. Transcripts

The transcripts of Dr. Lal Pathlabs Ltd.'s concall provide a detailed account of the discussions between the management team, analysts, and investors. These transcripts contain valuable information that aids in investment analysis and decision-making.

Dr. Lal Pathlabs Ltd. Investor Presentations

Dr. Lal Pathlabs Ltd.'s investor presentations provide an in-depth overview of the company's operations, future prospects, and growth strategy. By reviewing these presentations, investors can gain insights into Dr. Lal Pathlabs Ltd.'s long-term plans and evaluate its potential as an investment opportunity.

Dr. Lal Pathlabs Ltd. Promoters

Identifying the promoters of Dr. Lal Pathlabs Ltd. provides insights into the management team's involvement and influence over the company. Understanding the promoters helps in analyzing the company's ownership structure and potential conflicts of interest.

Dr. Lal Pathlabs Ltd. Shareholders

Analyzing the shareholder base of Dr. Lal Pathlabs Ltd. provides investors with insights into the company's ownership structure. Understanding the distribution of shares among various shareholders helps assess its potential impact on the company's stock performance and governance.

Dr. Lal Pathlabs Ltd. ROCE

Dr. Lal Pathlabs Ltd's Return on Capital Employed (ROCE) is a fundamental metric that evaluates the company's profitability and efficiency in utilizing its capital investments. Our stock analysis page offers the ROCE data for Dr. Lal Pathlabs Ltd, enabling investors to assess the company's ability to generate returns on the capital employed. By analyzing this ratio, investors can understand the company's financial performance and make informed investment decisions. Access detailed information on Dr. Lal Pathlabs Ltd's ROCE in the financials table or ratio section on our website.

Dr. Lal Pathlabs Ltd. EBITDA

Dr. Lal Pathlabs Ltd's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is a crucial measure for assessing the company's operational performance and profitability. By analyzing the company's core earnings, investors gain insights into its financial stability. Our stock analysis page provides comprehensive EBITDA data for Dr. Lal Pathlabs Ltd, allowing investors to evaluate the company's operational efficiency. You can find detailed EBITDA figures for Dr. Lal Pathlabs Ltd in the financials table or ratio section on our website.

Dr. Lal Pathlabs Ltd. DPS

Dr. Lal Pathlabs Ltd's Dividends Per Share (DPS) indicates the portion of profits distributed to shareholders in the form of dividends. Monitoring DPS is essential for investors seeking a consistent dividend income. On our stock analysis page, we present the DPS data for Dr. Lal Pathlabs Ltd, enabling investors to track the company's dividend history and payout ratio. You can find the detailed DPS information in the financials table or ratio section on our website.

Dr. Lal Pathlabs Ltd. EPS

Earnings Per Share (EPS) measures Dr. Lal Pathlabs Ltd's profitability on a per-share basis. By analyzing the company's EPS, investors can assess its earnings performance and growth potential. Our stock analysis page provides comprehensive EPS information for Dr. Lal Pathlabs Ltd, allowing investors to evaluate the company's profitability trends. Access the detailed EPS figures for Dr. Lal Pathlabs Ltd in the financials table or ratio section on our website to make informed investment decisions.

Read More
X